Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance
- 1 October 2019
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 138, 105012
Abstract
No abstract availableKeywords
Funding Information
- European Cooperation in Science and Technology (CA17104)
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (III41031)
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (CM1407)
This publication has 46 references indexed in Scilit:
- Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cellsin vitroJournal of Enzyme Inhibition and Medicinal Chemistry, 2012
- Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplificationBritish Journal of Cancer, 2012
- Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitorsJournal of Enzyme Inhibition and Medicinal Chemistry, 2012
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH MicroenvironmentMolecular Pharmaceutics, 2011
- Acidic stress promotes a glioma stem cell phenotypeCell Death & Differentiation, 2010
- pH control mechanisms of tumor survival and growthJournal of Cellular Physiology, 2010
- Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathwayEuropean Journal of Cell Biology, 2010
- A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein functionBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumoursHistopathology, 2006
- Expression of hypoxia-inducible carbonic anhydrases in brain tumorsNeuro-Oncology, 2005